CD8A and neoplasm: Therefore, TILs from mice vaccinated with the RNA-OG/pOVA-K10high vaccine may develop poor immunity by both upregulating PD-L1 in DCs and PD-1 in tumor-specific CD8+ T cells early on, leading to T cell exhaustion.